# Duravelo-4 (NCT06933329)

> Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06933329
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: BicycleTx Limited
- Conditions: Non-Small Cell Lung Cancer
- Interventions: Zelenectide pevedotin
- Enrollment: 73
- Primary outcome: Objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST 1.1) assessed by Investigator

## Indexed commentary on Duravelo-4 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=duravelo-4-nct06933329